Evidence map›Paper›PMID 42129351›Full record

Articlenpj antimicrobials and resistance2026

Mind the governance gap: a one health scoping review of national AMR performance indicators.

Emily T O'Neill, Uswa Shafaque, Vassilis Karadimitris, Brandon L Hill, Sruthi Ranganathan, Danilo Lo Fo Wong, Ketevan Kandelaki, Elias Mossialos, Michael Anderson

Abstract read
In one paragraph

Article in npj antimicrobials and resistance, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Emily T O'NeillLSE Health, The London School of Economics and Political Science, London, UK. E.oneill1@lse.ac.uk.
Uswa ShafaqueLSE Health, The London School of Economics and Political Science, London, UK.
Vassilis KaradimitrisLSE Health, The London School of Economics and Political Science, London, UK.
Brandon L HillLSE Health, The London School of Economics and Political Science, London, UK.
Sruthi RanganathanDepartment of Medicine, University of Cambridge, Cambridge, UK.
Danilo Lo Fo WongWorld Health Organization (WHO) Regional Office for Europe, Copenhagen, Denmark.
Ketevan KandelakiWorld Health Organization (WHO) Regional Office for Europe, Copenhagen, Denmark.
Elias MossialosDepartment of Health Policy, London School of Economics and Political Science, London, UK.
Michael AndersonLSE Health, The London School of Economics and Political Science, London, UK.

Funding

Novo Nordisk Fonden NNF24SA0099921
6 · The paper itself

Abstract

Despite several initiatives to benchmark national action in responding to antimicrobial resistance (AMR), no comprehensive inventory exists of indicators used across these efforts. We present a scoping review that maps and synthesises existing indicators used to assess national performance in addressing AMR. We conducted a review of academic and grey literature to identify quantitative and qualitative indicators used to assess national AMR performance across animal, environmental, and human health sectors. The academic search was conducted across MEDLINE, EMBASE, and Global Health. The grey literature search was conducted across multilateral organisations (e.g., WHO, FAO, WOAH, UNEP, OECD) and think-tanks. We categorised indicators into a thematic framework spanning 19 subdomains within three overarching domains: Governance & Leadership, Action Areas, and Monitoring & Evaluation. From 184 academic studies, we identified 2311 indicators, and 1406 from 48 grey literature sources. In total, 2101 were in human health, 675 in animal health, 232 in environmental health, and 709 were multisectoral. Within the three overarching domains, 281 were Governance & Leadership, 1907 were Action Areas, and 1671 were Monitoring & Evaluation indicators. When grouping indicators by subdomain, Surveillance & Laboratory (1427), Stewardship (765), and Prevention & Control (365) accounted for the largest volumes, followed by Social Determinants (232), Reporting (141), and Workforce (140), in contrast to Accountability (22), Transparency (22), and Equity (29). This comprehensive scoping review provides a One Health inventory of 3717 indicators used to assess national performance in responding to AMR. While revealing robust Surveillance & Laboratory, Prevention & Control, and Stewardship metrics, we identify critical gaps in Accountability, Transparency, and Equity. These measures comprise the Governance & Leadership domain, which is essential for policy implementation.

Identifiers

PMID42129351
PMCPMC13190849

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.